Exclusive news, analysis, and commentary on Big Pharma, hospitals, and biotech.
Moderna says it was willing to licence the tech but now wants to be repaid by rivals for vaccine revenue generated since then.
The figure was enough to push the insurance giant to a loss in Q1, despite its revenue beating expectations.
The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.
The filings signal the growing use cases for AI in healthcare settings, but also the risks that may accompany using AI in clinical care.
A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.
Demand for senior living facilities is inching back toward pre-pandemic levels. But how that demand will be met is still an open question.
Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.
The company’s stock ran higher after the company buoyed investors’ hopes that its technology will boost a lineup of new popular drugs.